[The status quo of pharmacotherapy of lipid metabolism disorders in the aged].

Abstract

The latest findings of arteriosclerosis and lipid metabolism research have shown that application of medicaments in the treatment of hyper- and dyslipoproteinaemias is necessary also at an advanced age, if dietary treatment fails. A consequent lipid normalisation suggests a decrease of arteriosclerotic effects. The expected benefit must be greater than possible side-effects of lipid regulatives. Lipid regulatives commonly used in the GDR are presented.

• Authors: V W Reuter
• Journal: Zeitschrift fur Alternsforschung (Z Alternsforsch) 1988 Jan-Feb Vol. 43 Issue 1 Pg. 43-6 ISSN: 0044-2224 [Print] Germany
• Vernacular Title: Status quo der Pharmakotherapie von Fettstoffwechselstörungen im Alter.
• PMID: 3281379 (Publication Type: English Abstract, Journal Article, Review)

Chemical References

• Hypolipidemic Agents

Topics

• Aged
• Arteriosclerosis (drug therapy)
• Humans
• Hypercholesterolemia (drug therapy)
• Hyperlipoproteinemias (drug therapy)
• Hypolipidemic Agents (therapeutic use)